Inventor · disambiguated record
Katie O'Callaghan
Also filed as: O'CALLAGHAN KATIE
0 granted patents·2 pending applications·0 citations·filing 2018–2023
Top patents by PatentIndex Score
2 records- 0166US2025326813A1Engineered interleukin-2 receptor beta reduced-binding agonistELPIS BIOPHARMACEUTICALS·Filed 2023·Application pending·0 cites
- 0235US2019381171A1Co-use of anti-bcma antibody and antibody-coupled t cell receptor (actr) in cancer therapy and b cell disordersUNUM THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katie O'Callaghan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →